Literature DB >> 24157042

Fabrication of a biodegradable xenoantigen-free rat liver scaffold for potential drug screening applications.

K H Hussein1, K-M Park, P K Teotia, J-W Yang, H-M Kim, S-H Hong, S-R Yang, I-C Park, S-M Park, H-M Woo.   

Abstract

BACKGROUND: The increasing market in biological pharmaceuticals raises the demand for human test systems. Although 2-dimensional (2D) models are mostly used for these purposes, these models not mimic responses of 3-dimensional (3D) native tissue.
METHODS: After generation of a rat liver scaffold using 0.1% sodium dodecyl sulfate, we characterized the histology, blood vessel integrity, and residual DNA as well as retained amounts of collagen and glycosaminoglycan (GAG). Then, we examined the susceptibility of extracellular matrix (ECM) to enzymatic remodeling. Finally, a mixed lymphocyte reaction (MLR) was performed to evaluate the in vitro immunogenicity of the ECM against human peripheral blood mononuclear cells (PBMCs).
RESULTS: Histologic examination of decellularized liver revealed the removal of nuclear and cytoplasmic materials with preservation of architecture. The vascular network was intact after decellularization. Biochemical analysis of ECM components revealed that only a negligible amount of DNA was retained compared with the native liver with preservation of large amounts of GAG and collagen. Scaffolds were degraded in response to collagenase treatment. MLR demonstrated that decellularized matrices did not exert any xenostimulatory response against human PBMCs.
CONCLUSION: Our findings suggested that naturally derived rat liver scaffolds show natural biocompatibility besides the ability to preserve the intact 3D structure and components. Because of these characteristics, the whole decellularized rat liver can retain many aspects of native tissue structure and function upon recellularization enabling it to be used for drug screening.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24157042     DOI: 10.1016/j.transproceed.2013.08.016

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

Review 1.  [Liver engineering as a new source of donor organs : A systematic review].

Authors:  F Mußbach; U Dahmen; O Dirsch; U Settmacher
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

2.  Bioengineered functional brain-like cortical tissue.

Authors:  Min D Tang-Schomer; James D White; Lee W Tien; L Ian Schmitt; Thomas M Valentin; Daniel J Graziano; Amy M Hopkins; Fiorenzo G Omenetto; Philip G Haydon; David L Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

Review 3.  3D tissue engineering, an emerging technique for pharmaceutical research.

Authors:  Gregory Jensen; Christian Morrill; Yu Huang
Journal:  Acta Pharm Sin B       Date:  2018-03-21       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.